Mulmit

ARS Pharmaceuticals, Inc.ARS Pharmaceuticals, Inc.

SPRY Nasdaq

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2025-12-3184,278,000-179,448,000-171,298,000-1.74
2024-12-3189,149,000-3,083,0007,998,0000.08
2023-12-3130,000-67,520,000-54,365,000-0.57
2022-12-311,316,000-35,516,000-34,682,000-0.87
2021-12-315,506,000-19,454,000-20,243,000-0.7

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-09-01Smith Margaret EkinsChief Commercial Officer1,001,738
2026-07-01Casale DonnPresident898,456
2026-06-24Kelly Michael30,000
2026-06-24Shah Pratik30,000
2026-06-24Islam Saqib30,000
2026-06-24Shawver Laura30,000
2026-06-24Thompson Peter A.30,000
2026-06-24SAUNDERS BRENT L30,000
2026-06-24RA CAPITAL MANAGEMENT, L.P.30,000
2026-06-24SCHNEIDER PHILLIP M30,000
2026-06-24Dadoo Rajeev30,000
2026-06-12Karas EricChief Commercial Officer25,000

8-K events

FiledItems
2026-08-13Results of operations · Financial statements and exhibits
2026-07-17Officer or director change
2026-07-07Officer or director change
2026-06-25Submission of matters to a vote
2026-05-15Results of operations · Regulation FD disclosure · Financial statements and exhibits
2026-05-13Officer or director change · Financial statements and exhibits
2026-03-09Results of operations · Regulation FD disclosure · Financial statements and exhibits
2025-11-10Results of operations · Regulation FD disclosure · Financial statements and exhibits
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…

Pharmaceutical Preparations — 같은 업종, 그리고 규모가 비슷한 기업Pharmaceutical Preparations — and other companies of a similar size

SEC가 같은 업종(Pharmaceutical Preparations)으로 분류한 기업이 먼저 오고, 그다음은 제출된 매출로 가까운 순입니다 — 가장 최근 연간 값이며, 연간 값이 없으면 최근 네 분기 합입니다. Companies the SEC assigns to the same industry (Pharmaceutical Preparations) come first, then the nearest by revenue as filed — the latest annual figure, or the last four quarters where no annual one is filed. 순서일 뿐 값이 싸거나 비싸다는 뜻이 아닙니다.Order only — it does not say a company is cheap or expensive.